MannKind Corp
MNKD
#6155
Rank
HK$8.30 B
Marketcap
HK$25.82
Share price
-3.80%
Change (1 day)
-32.02%
Change (1 year)

Earnings for MannKind Corp (MNKD)

Earnings in 2026 (TTM): -HK$0.39 Billion

According to MannKind Corp's latest financial reports the company's current earnings are HK$0.39 Billion. In 2025 the company made an earning of HK$11.04 Million a decrease over its 2024 earnings that were of HK$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MannKind Corp from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$0.39 Billion-3547.85%
2025 HK$11.04 M-95.39%
2024 HK$0.23 B-394.09%
2023 -HK$81.44 Million-88.13%
2022 -HK$0.69 Billion8%
2021 -HK$0.64 Billion40.84%
2020 -HK$0.46 Billion10.7%
2019 -HK$0.41 Billion-40.16%
2018 -HK$0.69 Billion-26.04%
2017 -HK$0.93 Billion-193.33%
2016 HK$0.98 B-134.11%
2015 -HK$2.9 Billion85.72%
2014 -HK$1.56 Billion3.6%
2013 -HK$1.51 Billion12.79%
2012 -HK$1.34 Billion5.58%
2011 -HK$1.27 Billion-5.72%
2010 -HK$1.34 Billion-22.51%
2009 -HK$1.73 Billion-27.37%
2008 -HK$2.38 Billion3.36%
2007 -HK$2.31 Billion27.18%
2006 -HK$1.81 Billion101.63%
2005 -HK$0.9 Billion50.46%
2004 -HK$0.6 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$54.20 B-14,296.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
HK$182.21 B-47,826.60%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
HK$263.63 B-69,150.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$60.34 B-15,905.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
HK$4.57 B-1,298.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-HK$1.21 Billion 214.70%๐Ÿ‡บ๐Ÿ‡ธ USA